Core Points - The annual general meeting of Shanghai Aladdin Biochemical Technology Co., Ltd. was held on May 15, 2025, with no rejected proposals [2] - All resolutions presented at the meeting were approved, including the annual reports and profit distribution plans [4][5][6] Meeting Details - The meeting took place at the company's office in Shanghai, with a combination of on-site and online voting methods [2] - The chairman, Mr. Xu Jiuzhen, presided over the meeting, ensuring compliance with relevant laws and regulations [2][3] Attendance - Out of 9 current directors, 7 attended the meeting, while all 3 supervisors were present [3] - The board secretary and all senior executives were also in attendance [3] Resolutions Passed - Key resolutions included the approval of the 2024 Board of Directors' work report, the 2024 Supervisory Board's work report, and the 2024 annual financial report [4][5] - The proposal for the 2025 financial budget and the reappointment of the auditing firm for 2025 were also approved [5][6] Legal Verification - The meeting was witnessed by lawyers from Shanghai Jintiancheng Law Firm, confirming that all procedures and resolutions were in accordance with the law [7] Management Appointment - On May 15, 2025, the board appointed Mr. Tan Xiaoyong as the vice president, effective immediately [8][9] - Mr. Tan holds 1,791,395 shares in the company and meets all qualifications for the position [10]
上海阿拉丁生化科技股份有限公司2024年年度股东大会决议公告